BioCentury
ARTICLE | Financial News

Blueprint Medicines proposes IPO

March 30, 2015 7:00 AM UTC

Blueprint Medicines, Cambridge, Mass. Business: Cancer Date announced: 2015-03-23 Type: IPO To be raised: Up to $100 million Shares: TBD Price: TBD Underwriters: Goldman Sachs; Cowen; JMP Securities; ...